Streetbeat News

Earnings

PFE

Pfizer Inc reported a Q3 adjusted EPS loss of $(0.17), beating the consensus loss of $(0.32). Q3 sales slumped by 42% to $13.23 billion, driven by a decline in COVID-19 product revenue. However, revenues for Pfizer's non-COVID products grew 10% operationally. The company recorded a $5.6 billion charge for inventory write-offs due to lower-than-expected use of COVID-19 products. Pfizer reaffirms FY23 guidance of revenues of $58-$61 billion and adjusted EPS of $1.45-$1.65.

Portfolio Pulse from Vandana Singh

October 31, 2023 | 12:41 pm

ASND

Ascendis Pharma A/S (NASDAQ:ASND) plans to report its Q3 2023 financial results and provide a business update on November 7, 2023. The company also announced its intention to resubmit its NDA for TransCon PTH for adults with hypoparathyroidism to the FDA before mid-November 2023. A conference call and webcast will be hosted on the same day to discuss the financial results and operations.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:39 pm

GOOG

GOOGL

GWW

META

On CNBC's 'Halftime Report Final Trades', Alphabet Inc., Meta Platforms, Inc., and W.W. Grainger, Inc. were named as final trades by Jim Lebenthal, Stephen Weiss, and Joseph Terranova respectively. Alphabet and Meta recently reported better-than-expected Q3 results, while Grainger reported better-than-expected earnings for Q3 and issued FY23 guidance.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 12:35 pm

VLCN

Volcon (NASDAQ:VLCN) reported Q3 sales of $487.43K, missing the analyst consensus estimate of $700.00K by 30.37%. However, this represents a 100.83% increase over sales of $242.71K in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:34 pm

BEN

Franklin Resources (NYSE:BEN) reported Q4 earnings of $0.84 per share, beating the analyst consensus estimate of $0.59 by 42.37%. This is a 7.69% increase from the same period last year. The company also reported quarterly sales of $1.99 billion, beating the analyst consensus estimate of $1.56 billion by 27.31%, a 2.42% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:31 pm

SCNI

Scinai Immunotherapeutics (NASDAQ:SCNI) reported Q3 losses of $(0.02) per share, a 133.33% decrease from the same period last year when it reported earnings of $0.06 per share.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:25 pm

PSMT

PriceSmart, Inc. (NASDAQ:PSMT) reported lower than expected earnings for Q4 2023, but sales exceeded estimates. The company's adjusted earnings were 65 cents per share, missing market estimates of 85 cents per share. Revenue was $1.118 billion, above expectations of $1.096 billion. The company's dividend yield is currently 1.28%, or $0.92 a year. To generate a monthly dividend income of $500, an investor would need to own approximately $467,432 worth of PriceSmart, or 6,522 shares. PriceSmart shares fell 0.7% to close at $71.67 on Monday.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 12:23 pm

NXRT

NexPoint Residential (NYSE:NXRT) reported Q3 core FFO per share of $0.65, down from $0.84 the previous year. The company's quarterly sales were $69.80 million, missing the analyst consensus estimate of $70.15 million by 0.50 percent. However, this represents a 2.57 percent increase over sales of $68.05 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:19 pm

ANET

Arista Networks Inc's shares are up by around 10% following the release of their Q3 FY23 results. The company reported a 28.3% Y/Y revenue growth to $1.509 billion, surpassing the consensus of $1.480 billion. Adjusted EPS was $1.83, beating the consensus of $1.58. The company's Q4 FY23 outlook expects revenues of $1.500 billion-$1.550 billion, adjusted gross margin of around 63%, and adjusted operating margin of approximately 42%.

Portfolio Pulse from Lekha Gupta

October 31, 2023 | 12:18 pm

HRMY

Harmony Biosciences reported Q3 2023 earnings per share (EPS) of $0.97, which may not compare to the estimated $0.65. The company's revenue was $160.268M, potentially surpassing the estimated $148.608M.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:16 pm